Inari Medical Inc (NAS:NARI)
$ 49.28 -1.01 (-2.01%) Market Cap: 2.87 Bil Enterprise Value: 2.85 Bil PE Ratio: 0 PB Ratio: 6.39 GF Score: 72/100

Q4 2020 Inari Medical Inc Earnings Call Transcript

Mar 09, 2021 / 09:30PM GMT
Release Date Price: $99.34 (+10.01%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to Inari Medical, Inc. Fourth Quarter 2020 Earnings Conference Call. (Operator Instructions) And now, I'd now like to introduce your host for today's program, Caroline Corner, Investor Relations. Please go ahead.

Caroline V. Corner
Westwicke Partners, LLC - MD

Thank you, operator. Welcome to Inari's Fourth Quarter and Full Year 2020 Earnings Call. Joining me on today's call are Bill Hoffman, President and Chief Executive Officer; and Mitch Hill, Chief Financial Officer.

This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the markets in which Inari operates; trends and expectations for Inari's products and technology; trends and demands for Inari's products; Inari's expected financial performance, expenses and position in the market; and the impact of COVID-19

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot